Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 3/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4926857 | 0.93 | KMT2A (0.55) | KMT2AMEN1ALDH1A1CA9GAA | |
| SCHEMBL4932148 | 0.89 | KMT2A (0.54) | KMT2AMEN1ALDH1A1CA9GAA | |
| SCHEMBL4923347 | 0.85 | MARS1 (0.53) | KMT2AMEN1 | |
| SCHEMBL5526223 | 0.85 | KMT2A (0.52) | KMT2AMEN1ALDH1A1CA9GAA | |
| SCHEMBL4927987 | 0.85 | KMT2A (0.54) | KMT2AMEN1ALDH1A1CA9GAA | |
| SCHEMBL4923427 | 0.84 | KMT2A (0.53) | KMT2AMEN1ALDH1A1CA9GAA | |
| SCHEMBL5517585 | 0.84 | KMT2A (0.58) | KMT2AMEN1ALDH1A1CA9GAA | |
| SCHEMBL5517559 | 0.83 | KMT2A (0.52) | KMT2AMEN1ALDH1A1CA9GAA | |
| SCHEMBL4927109 | 0.83 | KMT2A (0.52) | KMT2AMEN1ALDH1A1CA9GAA | |
| SCHEMBL5526183 | 0.83 | KMT2A (0.48) | KMT2AMEN1ALDH1A1CA9GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080064682-A1 | Pyrazole Derivatives | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2008-03-13 | — | — | US | disclosed |
| EP-1762568-A1 | PYRAZOLE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2007-03-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064682-A1 | Pyrazole Derivatives | NAT1, AR, CBR3 | KMT2A 1719/4885MEN1 3847/4885ALDH1A1 248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.